You are here

Article info

Article menu
Download PDFPDF
Epidemiology
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic

Authors

  • Naomi Serling-Boyd Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Kristin M D’Silva Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Tiffany YT Hsu Harvard Medical School, Boston, Massachusetts, USA Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Rachel Wallwork Department of Rheumatology, Johns Hopkins Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Xiaoqing Fu Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Ellen M Gravallese Harvard Medical School, Boston, Massachusetts, USA Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • April M Jorge Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Yuqing Zhang Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hyon Choi Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Jeffrey A Sparks Harvard Medical School, Boston, Massachusetts, USA Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Zachary S Wallace Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Clinical Epidemiology Program, Division of Rheumatology, Allergy, and Immunology, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Zachary S Wallace, Massachusetts General Hospital, Boston, MA 02114, USA; zswallace{at}mgh.harvard.edu
View Full Text

Citation

Serling-Boyd N, D’Silva KM, Hsu TY, et al
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
Annals of the Rheumatic Diseases 2021;80:660-666.

Publication history

  • Received October 12, 2020
  • Revised November 17, 2020
  • Accepted November 19, 2020
  • First published November 30, 2020.
Online issue publication 
April 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage